Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a hair loss condition caused by various factors and requires a thorough examination to diagnose and differentiate from other hair loss types.

Phospholipid-polymer hybrid nanoparticles could help treat hair loss by delivering quercetin effectively.

The new microneedle system effectively delivers minoxidil for hair regrowth with minimal side effects.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Non-laser devices show promise in treating hair issues, but more research is needed.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Chitosan is useful in skin treatments because it helps with wound healing and cell growth.

Microneedle patches with different pore sizes can effectively deliver drugs and trigger strong immune responses.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Brentuximab may cause hair to regain color.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Organoids created from stem cells are used to model diseases, test drugs, and develop personalized and regenerative medicine.

Skin organoids help improve wound healing and tissue repair.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Male hormones promote hair cell growth by using a growth factor from nearby skin cells.

Mogamulizumab can cause hair loss and skin rashes.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Targeting neurosteroids may help prevent drug relapse.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Microfluidic technology improves cell spheroid creation for better drug testing and tissue engineering.